LatugaNMGrantPCLevyKLuczkiewiczDL. Treatment of positive urine cultures at end-of-life and the effect on terminal delirium management. Am J Hospice Palliat Med. 2022;39:1014-1022. doi:10.1177/10499091211057848
2.
SarbeyB. Why standard drug treatments for the “death rattle” should be discontinued. J Palliat Med. 2022;25:180. doi:10.1089/jpm.2021.0568
3.
MercadanteS. Response to sarbey: Why standard drug treatments for the “death rattle” should be discontinued: death rattle in dying patients. J Palliat Med. 2022;25:703-704. doi:10.1089/jpm.2022.0081
4.
AgarMRLawlorPGQuinnS, et al.Efficacy of oral risperidone, haloperidol, or placebo for symptoms of delirium among patients in palliative care: A randomized clinical trial. JAMA Intern Med. 2017;177:34. doi:10.1001/jamainternmed.2016.7491
5.
GirardTDExlineMCCarsonSS, et al.Haloperidol and ziprasidone for treatment of delirium in critical illness. N Engl J Med. 2018;379:2506-2516. doi:10.1056/nejmoa1808217
6.
LeeKYTanECKHanrahanJRChircopCMichaelFOngJA. Effect of Antipsychotics and non-pharmacotherapy for the management of delirium in people receiving palliative care. J Pain Palliat Care Pharmacother. 2020;34:225-236. doi:10.1080/15360288.2020.1784353
